Insider Trading History of Macphee John A

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Macphee John A since 2007. This trader's CIK number is 1339976. At the time of last reporting, Macphee John A was the Director of Adamas Pharmaceuticals Inc. (stock ticker symbol ADMS). Also see all insider trading activities at Adamas Pharmaceuticals Inc.

Note that in the past MacPhee John A also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Par Pharmaceutical Companies, Inc. (PRX) by Macphee John A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 PRX 0 $0 39,910 $997,430 0 $0
2008 PRX 7,500 $79,702 0 $0 0 $0
2007 PRX 3,000 $56,100 0 $0 0 $0

Yearly summary of insider trading at Adamas Pharmaceuticals Inc (ADMS) by Macphee John A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 ADMS 0 $0 0 $0 192,000 $127,680


Insider trading activities at 2 companies by Macphee John A:

1. Par Pharmaceutical Companies, Inc. (PRX)

2. Adamas Pharmaceuticals Inc (ADMS)

Table 1. Insider trading of Par Pharmaceutical Companies, Inc. (PRX) by Macphee John A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-03-09 PRX Sale 39,910 24.99 997,430
2008-10-17 PRX Buy 7,500 10.63 79,702
2007-10-05 PRX Buy 3,000 18.70 56,100

Table 2. Insider trading of Adamas Pharmaceuticals Inc (ADMS) by Macphee John A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-03-12 ADMS Option Ex 192,000 .67 127,680

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Macphee John A (Director of Adamas Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.